SCHEMBL2198787

SCHEMBL2198787

Cc1cc(F)ccc1Nc1ccc(C(=O)c2cc(C(=O)NCCCN3CCOCC3)ccc2C)c(Cl)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 7/20 0.53
MAPK13 O15264 2/20 0.53
MAPK12 P53778 2/20 0.53
MAPK11 Q15759 2/20 0.53
NAMPT P43490 1/20 0.51
ALDH1A1 P00352 1/20 0.49
LMNA P02545 1/20 0.49
GAA P10253 1/20 0.49
MAPT P10636 1/20 0.49
HTT P42858 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
POLB P06746 1/20 0.47
CYP2C9 P11712 2/20 0.47
KMT2A Q03164 1/20 0.47
MAPK8 P45983 2/20 0.47
MAPK10 P53779 2/20 0.47
HTR7 P34969 1/20 0.46
CYP2D6 P10635 1/20 0.46
UBE2N P61088 1/20 0.46
CDK1 P06493 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2198608 0.83 MAPK14 (0.64) MAPK14MAPK13MAPK12MAPK11HTT
SCHEMBL2200850 0.83 MAPK14 (0.61) MAPK14MAPK13MAPK12MAPK11LMNA
SCHEMBL2201614 0.82 CYP2C9 (0.56) MAPK14ALDH1A1LMNASMN1; SMN2POLB
SCHEMBL2197033 0.82 MAPK14 (0.62) MAPK14MAPK13MAPK12MAPK11ALDH1A1
SCHEMBL2198303 0.80 MAPK14 (0.53) MAPK14MAPK13MAPK12MAPK11
SCHEMBL2198253 0.79 MAPK14 (0.51) MAPK14MAPK13MAPK12MAPK11ALDH1A1
SCHEMBL2200577 0.79 MAPK14 (0.52) MAPK14MAPK13MAPK12MAPK11
SCHEMBL2198281 0.79 MAPK13 (0.55) MAPK14MAPK13MAPK12MAPK11NAMPT
SCHEMBL2202867 0.78 MAPK14 (0.56) MAPK14MAPK13MAPK12MAPK11MAPT
SCHEMBL6022997 0.78 MAPK14 (0.54) MAPK14MAPK13MAPK12MAPK11NAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060166990-A1 Novel aminobenzophenone compounds LEO PHARMA A/S (DK) 2006-07-27 US claimed
US-7977387-B2 Aminobenzophenone compounds LEO PHARMA A/S (DK) 2011-07-12 US disclosed
US-7977387-B2 Aminobenzophenone compounds LEO PHARMA A/S (DK) 2011-07-12 US disclosed
US-7977387-B2 Aminobenzophenone compounds LEO PHARMA A/S (DK) 2011-07-12 US disclosed
US-20060166990-A1 Novel aminobenzophenone compounds LEO PHARMA A/S (DK) 2006-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060166990-A1 Novel aminobenzophenone compounds NFKBIA, UACA, ALDH7A1 MAPK14 697/4885MAPK13 1063/4885MAPK12 955/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.